F2-Isoprostanes as Novel Biomarkers for Type 2 Diabetes: a Review

Kaviarasan, Subramanian and Muniandy, Sekaran and Qvist, Rajes and Ismail, Ikram Shah (2009) F2-Isoprostanes as Novel Biomarkers for Type 2 Diabetes: a Review. Journal of Clinical Biochemistry and Nutrition, 45 (1). pp. 1-8. ISSN 0912-0009, DOI https://doi.org/10.3164/jcbn.08-266.

[img]
Preview
PDF
Kaviarasan-2009-F-2-Isoprostanes_as.pdf - Published Version

Download (261kB)
Official URL: https://doi.org/10.3164/jcbn.08-266

Abstract

Oxidative stress (OS) has been implicated as one of the major underlying mechanisms behind many acute and chronic diseases. However, the measurement of free radicals or their end products is complicated. Isoprostanes, derived from the non-enzymatic peroxidation of arachidonic acid are now considered to be reliable biomarkers of oxidant stress in the human body. Isoprostanes are involved in many of the human diseases such as type 2 diabetes. In type 2 diabetes elevated levels of F-2-Isoprostanes (F-2-IsoPs) have been observed. The measurement of bioactive F-2-IsoPs levels offers a unique noninvasive analytical tool to study the role of free radicals in physiology, oxidative stress-related diseases, and acute or chronic inflammatory conditions. Measurement of oxidative stress by various other methods lacks specificity and sensitivity. This review aims to shed light on the implemention of F-2-IsoPs measurement as a gold-standard biomarker of oxidative stress in type 2 diabetics.

Item Type: Article
Funders: UNSPECIFIED
Additional Information: Times Cited: 7 Kaviarasan, Subramanian Muniandy, Sekaran Qvist, Rajes Ismail, Ikram S.
Uncontrolled Keywords: Oxidative Stress; Lipid Peroxidation; Isoprostanes; Type 2 Diabetes
Subjects: R Medicine
Divisions: Faculty of Medicine
Depositing User: Ms Haslinda Lahuddin
Date Deposited: 11 Jul 2013 02:38
Last Modified: 14 Dec 2020 05:30
URI: http://eprints.um.edu.my/id/eprint/7217

Actions (login required)

View Item View Item